| Name | Title | Contact Details |
|---|
American Business Development Corporation (ABD) helps B2B service providers build scalable, high-impact business development (BD) operations. We specialize in structuring BD strategies, aligning marketing and outreach efforts, and securing key partnerships to drive growth. Whether through a customized Business Development Plan®, implementing BD processes, or serving as an outsourced BD team, ABD ensures companies have the tools, strategy, and execution needed to expand their client pipeline and increase revenue. ABD was founded on the belief that business development is built on relationships, not automation. We dont rely on spam emails or impersonal outreach. Instead, we focus on strategic engagement, tailored messaging, and real human connections to generate high-quality leads and long-term partnerships. Our expertise spans industries such as life sciences, medical devices, professional services, and international trade, helping companies break into new markets and optimize BD functions. For companies expanding into the U.S. market, ABD provides outsourced BD solutions, acting as a dedicated U.S.-based BD team. We represent companies at key industry conferences, execute outreach on partnering platforms, conduct meetings, and manage post-conference follow-up—ensuring that warm, engaged leads are seamlessly transferred to the clients internal team. This eliminates costly international travel while maximizing business development opportunities. ABD also supports export strategies, helping companies expand into foreign markets through strategic partnerships, trade mission planning, and regulatory alignment. With over 20 years of international economic development experience, we connect businesses with high-value clients and funding opportunities through government agencies, accelerators, and industry leaders. At ABD, we dont just generate leads—we build long-term, sustainable BD operations that drive growth beyond our engagement.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
AAA-Integration is an engineering service company, that emphasis on (Building Quality into Engineering Design). The evolution in engineering-design software during the past decade has permanently changed the engineering design concept. Three-dimensional computer-aided design, manufacturing and engineering (CAD/CAM/CAE) software programs are close to fulfilling their promise to deliver fully integrated design and manufacturing. CAD design software saves time and money in product development by reducing or eliminating the need for physical mock-ups, allowing for early detection of interference between components and enabling quick design iterations that result in product optimization. To further this integration, design engineering is taking new quality assurance concept. Attention to quality in the process-level used to produce engineering designs--in other words, attention to the data produced by digital modeling activities--is proving to be equally fruitful. Practitioners of design quality assurance and control are reaping great benefits by pushing quality awareness earlier into the engineering process.
Kaufman Dolowich LLP is a nationally recognized litigation law firm that has been serving the business and insurance communities since 1986. With 13 offices across the United States, Bermuda, and the United Kingdom, the firm has expanded from a boutique labor and employment practice into a comprehensive legal service provider. It offers a wide range of services, including labor and employment law, insurance coverage and litigation, professional liability, construction law, and more. The firm is known for its client-centered approach, focusing on developing innovative and cost-effective legal strategies tailored to various industries and complex legal matters. Kaufman Dolowichs attorneys are recognized leaders in their fields, often sharing their expertise at national conferences. The firm has a diverse clientele, including businesses and insurance carriers of all sizes, and has received accolades for its workplace culture, including multiple Mansfield Certification recognitions and being named among the “Best Companies to Work For” by U.S. News & World Report.